Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL327980 (E-4031) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
ChEMBL | Inhibition of tracer Red binding to human ERG expressed in membranes after 3 hrs by fluorescence polarization assay | B | 6.52 | pIC50 | <300 | nM | IC50 | J Med Chem (2019) 62: 4638-4655 [PMID:30998358] |
ChEMBL | Inhibition of human ERG expressed in cell membranes after 4 hrs by fluorescence polarization assay | B | 7.15 | pIC50 | 70 | nM | IC50 | Bioorg. Med. Chem. (2016) 24: 2954-2963 [PMID:27229618] |
ChEMBL | Inhibition of human ERG expressed in HEK293 cells by patch clamp assay | B | 7.57 | pIC50 | 27 | nM | IC50 | J Med Chem (2020) 63: 4506-4516 [PMID:32298114] |
ChEMBL | Inhibition of human ERG incubated for 3 hrs by competitive fluorescence tracer binding based assay | B | 7.62 | pIC50 | 24.2 | nM | IC50 | Eur J Med Chem (2021) 224: 113674-113674 [PMID:34237622] |
ChEMBL | Inhibition of human ERG expressed in CHOK1 cells assessed as inhibition of tail current after 5 mins by automated whole-cell patch clamp assay | B | 7.62 | pIC50 | 24 | nM | IC50 | Eur. J. Med. Chem. (2016) 117: 256-268 [PMID:27105029] |
ChEMBL | Inhibition of human ERG channel in HEK293 cells by voltage-clamp method | B | 7.64 | pIC50 | 22.91 | nM | IC50 | Eur. J. Med. Chem. (2008) 43: 2479-2488 [PMID:18262683] |
ChEMBL | Inhibition of human ERG incubated for 4 hrs by competitive fluorescence tracer binding based assay | B | 7.68 | pIC50 | 21 | nM | IC50 | Eur J Med Chem (2019) 183: 111684-111684 [PMID:31520926] |
ChEMBL | Inhibitory concentration against IKr potassium channel | B | 7.7 | pIC50 | 20 | nM | IC50 | Bioorg. Med. Chem. Lett. (2004) 14: 4771-4777 [PMID:15324906] |
ChEMBL | Inhibition of human Potassium channel HERG expressed in mammalian cells | B | 7.7 | pIC50 | 19.95 | nM | IC50 | Bioorg. Med. Chem. Lett. (2003) 13: 2773-2775 [PMID:12873512] |
ChEMBL | Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique | B | 7.7 | pIC50 | 19.95 | nM | IC50 | Bioorg. Med. Chem. (2008) 16: 6252-6260 [PMID:18448342] |
ChEMBL | Inhibitory concentration against potassium channel HERG | B | 7.7 | pIC50 | 19.95 | nM | IC50 | Bioorg. Med. Chem. Lett. (2005) 15: 2886-2890 [PMID:15911273] |
ChEMBL | Inhibition of human ERG | B | 7.92 | pIC50 | 12.02 | nM | IC50 | Eur. J. Med. Chem. (2011) 46: 618-630 [PMID:21185626] |
GtoPdb | - | - | 8.1 | pIC50 | 7.7 | nM | IC50 | Biophys J (1998) 74: 230-41 [PMID:9449325] |
ChEMBL | Inhibition of fluorescently labeled tracer binding to human ERG by competitive binding assay | B | 8.11 | pIC50 | 7.82 | nM | IC50 | Eur J Med Chem (2019) 175: 107-113 [PMID:31077996] |
ChEMBL | Inhibition of human ERG in MCF7 cells | B | 8.11 | pIC50 | 7.76 | nM | IC50 | Eur. J. Med. Chem. (2009) 44: 1926-1932 [PMID:19110341] |
ChEMBL | K+ channel blocking activity in human embryonic kidney cells expressing HERG Kv11.1 | F | 8.11 | pIC50 | 7.7 | nM | IC50 | J. Med. Chem. (2002) 45: 3844-3853 [PMID:12190308] |
ChEMBL | Inhibition of human ERG by fluorescently labeled tracer binding method | B | 8.92 | pIC50 | 1.2 | nM | IC50 | J Med Chem (2017) 60: 9205-9221 [PMID:29091425] |
ChEMBL | Inhibition of human ERG assessed as reduction of tail current | B | 7.6 | pEC50 | 25 | nM | EC50 | Eur. J. Med. Chem. (2015) 101: 627-639 [PMID:26204510] |
Kv11.1 in Rat [GtoPdb: 572] [UniProtKB: O08962] | ||||||||
GtoPdb | - | - | 7 | pKd | - | - | - | J Neurosci (1997) 17: 9423-32 [PMID:9390998] |
Kv10.1 in Human [GtoPdb: 570] [UniProtKB: O95259] | ||||||||
GtoPdb | - | - | 6.4 | pIC50 | - | - | - | Br J Pharmacol (2003) 138: 161-71 [PMID:12522086] |
Kv11.2 in Rat [GtoPdb: 573] [UniProtKB: O54853] | ||||||||
GtoPdb | - | - | 6.9 | pKd | - | - | - | J Neurosci (1997) 17: 9423-32 [PMID:9390998] |
Kv11.3 in Rat [GtoPdb: 574] [UniProtKB: O54852] | ||||||||
GtoPdb | - | - | 6.7 | pKd | - | - | - | J Neurosci (1997) 17: 9423-32 [PMID:9390998] |
ChEMBL data shown on this page come from version 31:
Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, CibriƔn-Uhalte E, Davies M, Dedman N, Karlsson A, MagariƱos MP, Overington JP, Papadatos G, Smit I, Leach AR. (2017) 'The ChEMBL database in 2017.' Nucleic Acids Res., 45(D1). DOI: 10.1093/nar/gkw1074. [PMCID:5210557]